방사선종양학

본문글자크기
  • [Breast Cancer Res Treat.] Recurrence outcomes after omission of postoperative radiotherapy following breast-conserving surgery for ductal carcinoma in situ of the breast: a multicenter, retrospective study in Korea (KROG 16-02).

    서울의대 / 김규보, 정소연, 신경환*

  • 출처
    Breast Cancer Res Treat.
  • 등재일
    2017 Feb
  • 저널이슈번호
    162(1):77-83. doi: 10.1007/s10549-017-4111-1. Epub 2017 Jan 12.
  • 내용

    바로가기  >

    Abstract

    PURPOSE:

    To evaluate the loco-regional recurrence (LRR) rate after breast-conserving surgery without postoperative radiotherapy (RT) for ductal carcinoma in situ (DCIS) of the breast.

     

    METHODS:

    Between 2000 and 2010, 311 DCIS patients from 9 institutions were analyzed retrospectively. The median age was 47 (range, 20-82). The median tumor size was 7 mm (range, 0.01-76). Margin width was <1 cm in 85 patients (27.3%), and nuclear grade was high in 37 patients (11.9%). Two hundred and three patients (65.3%) received tamoxifen.

     

    RESULTS:

    With a median follow-up of 74 months (range, 5-189), there were 11 local recurrences (invasive carcinoma in 6 and DCIS in 5) and 1 regional recurrence. The 7-year LRR rate was 3.8%. On univariate analysis, age and margin width were significant risk factors influencing LRR (p = 0.017 and 0.014, respectively). When age and margin width were combined among 211 patients whose margin width were available, the 7-year LRR rates were as follows (p < 0.001): (1) 0% in patients with age >50 years and any margin width status (n = 64), (2) 1.2% in age ≤50 years and margin width ≥1 cm (n = 93), (3) 13.1% in age ≤50 years and margin width <1 cm (n = 54).

     

    CONCLUSIONS:

    The LRR rate was very low in selected DCIS patients treated with breast-conserving surgery without postoperative RT. However, adjuvant RT should be considered for those with age ≤50 years and margin width <1 cm.

     

    Author information

    Kim K1, Jung SY2, Shin KH3, Kim JH4, Han W5, Lee HB5, Huh SJ6, Choi DH6, Park W6, Ahn SD7, Kim SS7, Kim JH8, Suh CO9, Kim YB9, Kim IA4,10, Kim S4,11, Kim YJ1.

    Department of Radiation Oncology, Ewha Womans University School of Medicine, Seoul, Republic of Korea.

    Center for Breast Cancer, National Cancer Center, Goyang, Gyeonggi, Republic of Korea.

    Department of Radiation Oncology, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Republic of Korea. radiat@snu.ac.kr.

    Department of Radiation Oncology, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Republic of Korea.

    Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.

    Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

    Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

    Department of Radiation Oncology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Republic of Korea.

    Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.

    10 Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Republic of Korea.

    11 Department of Radiation Oncology, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea.

     

  • 키워드
    Age; Ductal carcinoma in situ; Radiation therapy; Resection margin​
  • 덧글달기
    덧글달기
       IP : 3.17.128.129

    등록